In the Know: Key Abstracts from the American Society of Hematology 2021 Annual Meeting in Acute Lymphoblastic Leukemia
Poster 4 Pre-assessment

Before you view the poster session, please take this pre-assessment. Taking this pre-assessment does not immediately qualify learners to earn credit.

Certificates of credit will only be sent to learners who also receive a passing score on the post-test (separate from this survey), and fill out the evaluation form and application for credit.

Question Title

* 1. What are your credentials?

MD/DO

Nurse

Other (please specify)

Question Title

* 2. What is your specialty?

Oncology

Hematology

Pediatrics

Primary Care/Family Medicine

Other (please specify)

Question Title

* 3. How confident are you in the management of patients with ALL in your practice?

Very confident

Confident

Neutral

Little confidence

No confidence

Very confident

Confident

Neutral

Little confidence

No confidence

Question Title

* 4. In the 3 clinical trials SWOG 1318, EWALL-INO, and INITIAL-1, which of the following outcomes were observed in elderly patients with Ph-ALL?

Low rate of secondary malignancies

Low rate of late relapses

Low rate of induction deaths

Low rate of complete response

Question Title

* 5. Which of the following interventions was evaluated in attempt to improve both the efficacy and tolerability of therapy in the SWOG1318 study in elderly patients with Ph-ALL?

Omission of chemotherapy in induction and consolidation

Omission of maintenance chemotherapy

Dose reduction of chemotherapy in induction and consolidation

Dose reduction of blinatumomab by 50%

Question Title

* 6. Please let us know who you are so we can connect your responses to your post-test & application to claim CME credit (completed after participating in the activity)

First & Last Name

State/Province

ZIP/Postal Code

Country

Email Address

In the Know: Key Abstracts from the American Society of Hematology 2021 Annual Meeting in Acute Lymphoblastic Leukemia***Poster 4 Pre-assessment***

Question Title

* 1. What are your credentials?

Question Title

* 2. What is your specialty?

Question Title

* 3. How confident are you in the management of patients with ALL in your practice?

Question Title

* 4. In the 3 clinical trials SWOG 1318, EWALL-INO, and INITIAL-1, which of the following outcomes were observed in elderly patients with Ph-ALL?

Question Title

* 5. Which of the following interventions was evaluated in attempt to improve both the efficacy and tolerability of therapy in the SWOG1318 study in elderly patients with Ph-ALL?

Question Title

* 6. Please let us know who you are so we can connect your responses to your post-test & application to claim CME credit (completed after participating in the activity)

In the Know: Key Abstracts from the American Society of Hematology 2021 Annual Meeting in Acute Lymphoblastic Leukemia
Poster 4 Pre-assessment